RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether following Carbon dioxide (CO2) laser treatment, application of autologous cell suspension obtained via enzymatic and mechanical preparation will reduce negative side effects from CO2 laser and decrease the time of healing following treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Collaborator: Avita Medical

Criteria

Inclusion Criteria:

• Adults 18 years or older

• Patients undergoing facelift with perioral CO2 laser treatment

• Skin that is Fitzpatrick Score 1 or 2

Exclusion Criteria:

• Prior perioral CO2 laser resurfacing

• Allergy to components of preparation system